Control group:ECT

3 trials

Sponsors

Shenzhen Kangning Hospital, Second People's Hospital of Huizhou

Conditions

DepressionSchizophreniamajor depressive disorder

Early Phase 1

Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression

RecruitingChiCTR1900022905

Shenzhen Kangning HospitalDepression

Start: 2019-05-05Updated: 2019-10-28

The effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with major depression disorder: a parallel-group, double-blinded, randomized, controlled, noninferiority pilot trial

RecruitingChiCTR1900027701

Second People's Hospital of Huizhoumajor depressive disorder

Start: 2019-11-28Updated: 2020-06-08

The effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in schizophrenia patients: a parallel-group, double-blinded, randomized, controlled, noninferiority pilot trial

RecruitingChiCTR2000033507

Second People's Hospital of HuizhouSchizophrenia

Start: 2020-06-01Updated: 2020-06-08

Related Papers

Improved Safety of Hybrid Electroconvulsive Therapy Compared With Standard Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Randomized, Double-Blind, Parallel-Group Pilot Trial

Frontiers in Psychiatry2022-05-2313 citations

Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression.

2019-11-068 citations